Sign In
Buy BMY
$54.70
+0.700 (+1.30%)
At Close: Jun 22, 2026
3 Reasons to Buy Bristol Myers Squibb Stock
02:53pm, Monday, 22'nd Jun 2026
Bristol Myers Squibb has a big revenue gap to fill, but it seems up to the challenge. Its robust dividend yield will pay investors handsomely to wait things out.
Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026
06:59am, Thursday, 18'th Jun 2026
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026.
Bristol Myers Squibb Announces Dividend
04:16pm, Wednesday, 17'th Jun 2026
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Dividend.
Elicio Therapeutics Points To Durable Responses As It Maps Next Steps For Lead Cancer Drug
12:43pm, Wednesday, 17'th Jun 2026
Elicio Therapeutics Inc. (NASDAQ:ELTX) stock is up on Wednesday as the company reported promising clinical observations regarding its ELI-002 7P treatment.
The Healthcare M&A Wave
12:30pm, Wednesday, 17'th Jun 2026
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
3 Stocks to Invest In to Rebalance Your Portfolio
12:00pm, Wednesday, 17'th Jun 2026
#TheMorningFilter #PortfolioRebalance #StockInvesting These value stocks can balance portfolios heavy in growth stocks—and they're undervalued, too. Watch The Morning Filter: https://www.youtube.com
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
10:02am, Wednesday, 17'th Jun 2026
Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
Interest Rates Are Going Higher: 4 High-Yield Passive Income Stocks Can Weather Any Storm
08:48am, Wednesday, 17'th Jun 2026
Converging forces are pushing rates higher in 2026. The Iran conflict closed the Strait of Hormuz, spiking crude oil prices and raising production and transport costs. This energy shock drove inflatio
Can BMY's Camzyos Strengthen Its Cardiovascular Portfolio?
03:21pm, Tuesday, 16'th Jun 2026
Bristol Myers eyes growth from Camzyos as the FDA reviews its use in adolescents with obstructive HCM, expanding the drug's market reach.
3 Dividend Stocks to Hold for the Long Haul
06:15am, Tuesday, 16'th Jun 2026
These three healthcare leaders are slowly overcoming recent obstacles. They have strong dividend track records and the means to maintain healthy dividend growth.
A Dramatic Shift in Fed Policy Just Unlocked a New Era for Bristol Myers Squibb
10:50am, Monday, 15'th Jun 2026
With the 10-Year Treasury yielding 4.48% and the Fed signaling more cuts ahead, income investors are hunting for yield that compounds.
How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.
06:15pm, Saturday, 13'th Jun 2026
Bristol Myers Squibb's yield is well above the pharma average, and it has patent expirations on the horizon. The payout ratio isn't outlandishly high, and the company is financially strong, as it deal
Can Bristol Myers' Growth Portfolio Offset Legacy Drug Declines?
02:20pm, Friday, 12'th Jun 2026
BMY's growth portfolio now drives more than half of revenues, with strong gains from Reblozyl, Breyanzi and Cobenfy helping offset legacy drug declines.
Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today
06:46pm, Thursday, 11'th Jun 2026
Bristol Myers Squibb (BMY) closed at $56.87 in the latest trading session, marking a +2.28% move from the prior day.
Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.
02:02pm, Thursday, 11'th Jun 2026
Multiple patent cliffs raise concerns about whether Bristol Myers Squibb can maintain its dividend growth streak. $3.5 billion in anticipated annual cost savings could help the pharmaceutical company
